A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
Pompe disease (PD) is a glycogen storage disorder caused by deficient activity of acid alpha-glucosidase (GAA). We sought to review the latest available evidence on the safety and efficacy of recombinant human GAA enzyme replacement therapy (ERT) for late-onset PD (LOPD). Methods: We systematically...
Guardado en:
Autores principales: | Alícia Dorneles Dornelles, Ana Paula Pedroso Junges, Tiago Veiga Pereira, Bárbara Corrêa Krug, Candice Beatriz Treter Gonçalves, Juan Clinton Llerena, Priya Sunil Kishnani, Haliton Alves de Oliveira, Ida Vanessa Doederlein Schwartz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c5d900c95db4428981b0e9388357da8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Antonietta Tarallo, et al.
Publicado: (2021) -
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
por: Zhang B, et al.
Publicado: (2016) -
Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
por: Javier de las Heras, et al.
Publicado: (2021) -
Molecular study of Pompe disease in Egyptian infants
por: Mona Essawi, et al.
Publicado: (2021) -
Individualized Assessment of Exercise Capacity in Response to Acute and Long-Term Enzyme Replacement Therapy in Pediatric Pompe Disease
por: Ronen Bar-Yoseph, et al.
Publicado: (2021)